| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | EDGE THERAPEUTICS INC | 2,344,868 | 23,707,000 | 20.40% | ||
| 2 | VERSARTIS INC COM | 2,039,223 | 22,554,000 | 19.40% | ||
| 3 | WAVE LIFE SCIENCES LTD | 784,159 | 16,224,000 | 13.96% | ||
| 4 | Oxford Immunotec Global PLC | 1,377,497 | 12,397,000 | 10.67% | ||
| 5 | DIMENSION THERAPEUTICS INC COM | 2,059,283 | 12,356,000 | 10.63% | ||
| 6 | DYNAVAX TECHNOLOGIES CORP | 454,881 | 6,632,000 | 5.71% | ||
| 7 | DERMIRA INC | 196,544 | 5,749,000 | 4.95% | ||
| 8 | ALDER BIOPHARMACEUTICALS INC | 190,806 | 4,764,000 | 4.10% | ||
| 9 | SAGE THERAPEUTICS | 156,958 | 4,729,000 | 4.07% | ||
| 10 | AVEO PHARMACEUTICALS INC | 2,590,673 | 2,490,000 | 2.14% | ||
| 11 | KARYOPHARM THERAPEUTICS INC COM | 222,947 | 1,496,000 | 1.29% | ||
| 12 | VistaGen Therapeutics Inc | 352,950 | 1,377,000 | 1.18% | ||
| 13 | ADAPTIMMUNE THERAPEUTICS PLC | 127,041 | 1,035,000 | 0.89% | ||
| 14 | TRILLIUM THERAPEUTICS INC | 80,759 | 725,000 | 0.62% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001631614-16-000006, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
